Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Taubert

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
Molecular Therapy. Nucleic Acids|April 2, 2019
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In VivoSven Wach, Madeleine Brandl, Hannes Borchardt, et al.
Cancer Research|June 16, 2012
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancerKristiaan Lenos, Anna M Grawenda, Kirsten Lodder, et al.
Cells|June 2, 2021
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS LesionsBastian Keck, Angelika Borkowetz, Julia Poellmann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 15, 2018
Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitionIzabella Thaís Silva, Jennifer Munkert, Elke Nolte, et al.
Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
International Journal of Molecular Sciences|September 27, 2019
Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor MetabolismMatthias Kappler, Ulrike Pabst, Claus Weinholdt, et al.
Carcinogenesis|September 6, 2021
Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastasesAnne Offermann, Duan Kang, Christian Watermann, et al.
Planta Medica|May 10, 2017
Production of the Cytotoxic Cardenolide Glucoevatromonoside by Semisynthesis and Biotransformation of Evatromonoside by a Digitalis lanata Cell CultureJennifer Munkert, Marina Santiago Franco, Elke Nolte, et al.
Urology|June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor TherapyKarl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
Molecular Therapy. Nucleic Acids|April 2, 2019
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In VivoSven Wach, Madeleine Brandl, Hannes Borchardt, et al.
Cancer Research|June 16, 2012
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancerKristiaan Lenos, Anna M Grawenda, Kirsten Lodder, et al.
Cells|June 2, 2021
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS LesionsBastian Keck, Angelika Borkowetz, Julia Poellmann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 15, 2018
Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitionIzabella Thaís Silva, Jennifer Munkert, Elke Nolte, et al.
Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
International Journal of Molecular Sciences|September 27, 2019
Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor MetabolismMatthias Kappler, Ulrike Pabst, Claus Weinholdt, et al.
Carcinogenesis|September 6, 2021
Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastasesAnne Offermann, Duan Kang, Christian Watermann, et al.
Planta Medica|May 10, 2017
Production of the Cytotoxic Cardenolide Glucoevatromonoside by Semisynthesis and Biotransformation of Evatromonoside by a Digitalis lanata Cell CultureJennifer Munkert, Marina Santiago Franco, Elke Nolte, et al.
Urology|June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor TherapyKarl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Pageof 17